HZNP-HZN-825-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HZNP-HZN-825-301, covering 2026-01-05 to 2026-01-05. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) [Phase 2]